These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 28614209

  • 1. Newly Described Entities in Salivary Gland Pathology.
    Skálová A, Gnepp DR, Lewis JS, Hunt JL, Bishop JA, Hellquist H, Rinaldo A, Vander Poorten V, Ferlito A.
    Am J Surg Pathol; 2017 Aug; 41(8):e33-e47. PubMed ID: 28614209
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sclerosing Polycystic Adenoma of Salivary Glands: A Novel Neoplasm Characterized by PI3K-AKT Pathway Alterations-New Insights Into a Challenging Entity.
    Skálová A, Baněčková M, Laco J, Di Palma S, Agaimy A, Ptáková N, Costes-Martineau V, Petersson BF, van den Hout MFCM, de Rezende G, Klubíčková N, Koblížek M, Koshyk O, Vaneček T, Leivo I.
    Am J Surg Pathol; 2022 Feb 01; 46(2):268-280. PubMed ID: 34510113
    [Abstract] [Full Text] [Related]

  • 5. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
    Hsieh MS, Lee YH, Chang YL.
    Hum Pathol; 2016 Oct 01; 56():134-42. PubMed ID: 27327192
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
    Skálová A, Stenman G, Simpson RHW, Hellquist H, Slouka D, Svoboda T, Bishop JA, Hunt JL, Nibu KI, Rinaldo A, Vander Poorten V, Devaney KO, Steiner P, Ferlito A.
    Am J Surg Pathol; 2018 Feb 01; 42(2):e11-e27. PubMed ID: 29076877
    [Abstract] [Full Text] [Related]

  • 8. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands.
    Skálová A, Hyrcza MD, Leivo I.
    Head Neck Pathol; 2022 Mar 01; 16(1):40-53. PubMed ID: 35312980
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?
    Projetti F, Lacroix-Triki M, Serrano E, Vergez S, Barres BH, Meilleroux J, Delisle MB, Uro-Coste E.
    J Oral Pathol Med; 2015 Apr 01; 44(4):244-51. PubMed ID: 25040635
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
    Connor A, Perez-Ordoñez B, Shago M, Skálová A, Weinreb I.
    Am J Surg Pathol; 2012 Jan 01; 36(1):27-34. PubMed ID: 21989350
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Salivary gland tumor "wishes" to add to the next WHO Tumor Classification: sclerosing polycystic adenosis, mammary analogue secretory carcinoma, cribriform adenocarcinoma of the tongue and other sites, and mucinous variant of myoepithelioma.
    Gnepp DR.
    Head Neck Pathol; 2014 Mar 01; 8(1):42-9. PubMed ID: 24595421
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aspiration cytology of mammary analogue secretory carcinoma of the salivary gland.
    Jung MJ, Kim SY, Nam SY, Roh JL, Choi SH, Lee JH, Baek JH, Cho KJ.
    Diagn Cytopathol; 2015 Apr 01; 43(4):287-93. PubMed ID: 25087572
    [Abstract] [Full Text] [Related]

  • 18. Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib.
    Cipriani NA, Blair EA, Finkle J, Kraninger JL, Straus CM, Villaflor VM, Ginat DT.
    Int J Surg Pathol; 2017 Oct 01; 25(7):613-618. PubMed ID: 28497708
    [Abstract] [Full Text] [Related]

  • 19. Emerging Entities in Salivary Pathology: A Practical Review of Sclerosing Microcystic Adenocarcinoma, Microsecretory Adenocarcinoma, and Secretory Myoepithelial Carcinoma.
    Rooper LM.
    Surg Pathol Clin; 2021 Mar 01; 14(1):137-150. PubMed ID: 33526218
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.